2021 Marked New Era Of Domestic Collaboration in China

But M&A Outlook Still Muted?

 
• By Dexter Jie Yan
  
2021 or 2022 first year of collaborations
past year unveiled a new era of collaborations between biotechs and biopharmas in China • Source: Alamy

More from China

More from Focus On Asia